Arax Advisory Partners’s iShares Biotechnology ETF IBB Stock Holding History

Arax Advisory Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$935K	Buy	4,914 +3,249	+195%	+$558K	0.01%	1251
2026 Q1	$281K	Buy	1,665 +1,197	+256%	+$205K	0.01%	903
2025 Q4	$79K	Buy	+468	New	+$76K	﹤0.01%	1420
2025 Q3	–	Sell	-649	Closed	-$82.2K	–	3917
2025 Q2	$82.2K	Hold	649	–	–	﹤0.01%	1027
2025 Q1	$83.1K	Sell	649 -4	-0.6%	-$542	0.01%	779
2024 Q4	$86.4K	Hold	653	–	–	0.01%	722
2024 Q3	$95.1K	Buy	653 +101	+18%	+$14.6K	0.01%	504
2024 Q2	$75.8K	Buy	552 +480	+667%	+$64.1K	0.01%	534
2024 Q1	$9.9K	Buy	72 +4	+6%	+$546	﹤0.01%	779
2023 Q4	$9.25K	Hold	68	–	–	﹤0.01%	771
2023 Q3	$8.33K	Hold	68	–	–	﹤0.01%	766
2023 Q2	$8.65K	Hold	68	–	–	﹤0.01%	738
2023 Q1	$8.8K	Hold	68	–	–	﹤0.01%	713
2022 Q4	$8.94K	Sell	68 -72	-51%	-$9.3K	﹤0.01%	665
2022 Q3	$16K	Hold	140	–	–	﹤0.01%	596
2022 Q2	$16K	Hold	140	–	–	﹤0.01%	585
2022 Q1	$18K	Hold	140	–	–	﹤0.01%	584
2021 Q4	$21K	Buy	+140	New	+$21.7K	﹤0.01%	564
2020 Q4	$11K	Sell	70 -71	-50%	-$10.1K	﹤0.01%	555
2020 Q3	$19K	Buy	+141	New	+$19.1K	﹤0.01%	477
2020 Q1	–	Sell	-182	Closed	-$22K	–	697
2019 Q4	$22K	Hold	182	–	–	0.01%	410
2019 Q3	$18K	Sell	182 -6	-3%	-$628	0.01%	416
2019 Q2	$20K	Buy	+188	New	+$20K	0.01%	410
2018 Q4	$17K	Hold	181	–	–	0.01%	389
2018 Q3	$22K	Buy	+181	New	+$21.3K	0.01%	391

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Arax Advisory Partners's IBB Position: Q2 2026 in Review

Arax Advisory Partners increased its iShares Biotechnology ETF (IBB) stake by 195% in Q2 2026, buying an estimated $558K and bringing the position to 4,914 shares worth $935K. The position accounts for 0.01% of the portfolio, ranked #1251.

Arax Advisory Partners first reported a position in IBB in Q3 2018 and has held it in 25 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Arax Advisory Partners held 4,914 shares of iShares Biotechnology ETF worth $935K as of Q2 2026.
Arax Advisory Partners bought 3,249 iShares Biotechnology ETF shares in Q2 2026, an estimated $558K.
iShares Biotechnology ETF made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1251 holding.
Arax Advisory Partners first reported a position in iShares Biotechnology ETF in Q3 2018 and has held it in 25 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.